Grieco S, Johnston K, Gao P, Garduno B, Tang B, Yi E
Mol Psychiatry. 2023; 28(12):5293-5308.
PMID: 37443194
PMC: 11041731.
DOI: 10.1038/s41380-023-02153-5.
LaVigne J, Alles S
Neurobiol Pain. 2022; 11:100092.
PMID: 35571964
PMC: 9097710.
DOI: 10.1016/j.ynpai.2022.100092.
Bernard A, Danigo A, Bourthoumieu S, Mroue M, Desmouliere A, Sturtz F
Pharmaceuticals (Basel). 2021; 14(11).
PMID: 34832967
PMC: 8618735.
DOI: 10.3390/ph14111185.
Rehfeld J
Molecules. 2021; 26(18).
PMID: 34577128
PMC: 8469898.
DOI: 10.3390/molecules26185657.
Huang Z, Tatti R, Loeven A, Landi Conde D, Fadool D
Front Cell Neurosci. 2021; 15:662184.
PMID: 34239417
PMC: 8259627.
DOI: 10.3389/fncel.2021.662184.
Cholecystokinin and the hormone concept.
Rehfeld J
Endocr Connect. 2021; 10(3):R139-R150.
PMID: 33640870
PMC: 8052576.
DOI: 10.1530/EC-21-0025.
Panic disorders: The role of genetics and epigenetics.
Kim E, Kim Y
AIMS Genet. 2019; 5(3):177-190.
PMID: 31435520
PMC: 6690230.
DOI: 10.3934/genet.2018.3.177.
Neuropeptides at the crossroad of fear and hunger: a special focus on neuropeptide Y.
Comeras L, Herzog H, Tasan R
Ann N Y Acad Sci. 2019; 1455(1):59-80.
PMID: 31271235
PMC: 6899945.
DOI: 10.1111/nyas.14179.
Novel Pharmacological Nonopioid Therapies in Chronic Pain.
Kaye A, Cornett E, Hart B, Patil S, Pham A, Spalitta M
Curr Pain Headache Rep. 2018; 22(4):31.
PMID: 29616344
DOI: 10.1007/s11916-018-0674-8.
Peptides in metabolic autonomic nerves.
Uvnas-Wallensten K
Diabetologia. 2016; 20(Suppl 1):337-342.
PMID: 27942820
DOI: 10.1007/BF00254501.
Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches.
Balmus I, Ciobica A, Antioch I, Dobrin R, Timofte D
Oxid Med Cell Longev. 2016; 2016:3975101.
PMID: 27563374
PMC: 4983669.
DOI: 10.1155/2016/3975101.
Circulating immunoreactive substance P in man.
Skrabanek P, Cannon D, Kirrane J, Legge D, Powell D
Ir J Med Sci. 2016; 145(1):399.
PMID: 27517263
DOI: 10.1007/BF02938979.
Functional synergy between cholecystokinin receptors CCKAR and CCKBR in mammalian brain development.
Nishimura S, Bilguvar K, Ishigame K, Sestan N, Gunel M, Louvi A
PLoS One. 2015; 10(4):e0124295.
PMID: 25875176
PMC: 4398320.
DOI: 10.1371/journal.pone.0124295.
Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.
Bowers M, Ressler K
Neuropsychopharmacology. 2014; 40(3):688-700.
PMID: 25176168
PMC: 4289957.
DOI: 10.1038/npp.2014.225.
50 years of hurdles and hope in anxiolytic drug discovery.
Griebel G, Holmes A
Nat Rev Drug Discov. 2013; 12(9):667-87.
PMID: 23989795
PMC: 4176700.
DOI: 10.1038/nrd4075.
Cholecystokinin: an excitatory modulator of mitral/tufted cells in the mouse olfactory bulb.
Ma J, Dankulich-Nagrudny L, Lowe G
PLoS One. 2013; 8(5):e64170.
PMID: 23691163
PMC: 3655022.
DOI: 10.1371/journal.pone.0064170.
Female mice lacking cholecystokinin 1 receptors have compromised neurogenesis, and fewer dopaminergic cells in the olfactory bulb.
Sui Y, Vermeulen R, Hokfelt T, Horne M, Stanic D
Front Cell Neurosci. 2013; 7:13.
PMID: 23459364
PMC: 3584826.
DOI: 10.3389/fncel.2013.00013.
Decreased expression of the satiety signal receptor CCKAR is responsible for increased growth and body weight during the domestication of chickens.
Dunn I, Meddle S, Wilson P, Wardle C, Law A, Bishop V
Am J Physiol Endocrinol Metab. 2013; 304(9):E909-21.
PMID: 23443924
PMC: 3651647.
DOI: 10.1152/ajpendo.00580.2012.
Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.
Shlik J, Vasar E, Bradwejn J
CNS Drugs. 2013; 8(2):134-52.
PMID: 23338219
DOI: 10.2165/00023210-199708020-00005.
Infant satiety depends on transient expression of cholecystokinin-1 receptors on ependymal cells lining the third ventricle in mice.
Ozaki T, Mohammad S, Morioka E, Takiguchi S, Ikeda M
J Physiol. 2012; 591(5):1295-312.
PMID: 23266937
PMC: 3607872.
DOI: 10.1113/jphysiol.2012.247676.
